Monitoring and management of antitubercu
โ
SUBHASH AGAL; RAJIV BAIJAL; SNEHANSHU PRAMANIK; NIKHIL PATEL; PARIJAT GUPTE; PRA
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 137 KB
## Abstract **Background:** Hepatotoxicity to antituberculosis therapy (ATT) poses a major challenge. This often results in inadequate therapy. The risk of fulminant hepatic failure and mortality is high once icteric hepatitis develops. There is no consensus on monitoring protocols and for the rein